"Study","Study.year","Analysis.name","Analysis.number","Subgroup.number","Experimental.cases","Experimental.N","Control.cases","Control.N","Experimental.mean","Experimental.SD","Control.mean","Control.SD","GIV.Mean","GIV.SE","Mean","CI.start","CI.end","Variance","Weight","analysis_key","dataset_name","exp_cases_gt_n","ctrl_cases_gt_n","exp_cases_lt0","ctrl_cases_lt0","exp_n_le0","ctrl_n_le0","exp_cases_nonint","ctrl_cases_nonint","exp_n_nonint","ctrl_n_nonint","double_zero","all_events","sparse_events","exp_sd_le0","ctrl_sd_le0","variance_negative","giv_se_negative","ci_inverted","ci_mismatch"
"Sookprasert 2014",2014,"Quality of life via FACT (short term)",1,1,0,88,0,38,69.28,43.42,66.68,45.7,0,8.74255121086752,2.6,-14.529691,19.729691,76.4322016746411,0,"1::1","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE
"Grutsch 2021",2021,"Change in quality of life after treatment via QLQ-C30 (short term)",2,1,0,38,0,18,2.415789,33.529338,-13.4,38.183766,0,1.40964450913502,15.815789,-4.795042,36.42662,1.9870976421345,0,"2::1","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE
"Grutsch 2021",2021,"Change in quality of life after treatment via QLI (short term)",3,1,0,33,0,15,1.172727,4.269095,-0.5,4.64758,0,1.41148075914177,1.672727,-1.093724,4.439178,1.99227793342742,0,"3::1","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE
"Sookprasert 2014",2014,"Quality of life via FACT (intermediate term)",4,1,0,88,0,38,42.54,48.62,28.25,45.72,0,0,14.29,-3.444255,32.024255,0,0,"4::1","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE
"Grutsch 2021",2021,"Change in sleep after treatment via PSQI (short term)",5,1,0,31,0,19,-2.1968,3.2725,-5,5.2307,0,1.33621539769315,2.8032,0.184266,5.422134,1.78547158903226,0,"5::1","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE
"Kartini 2021",2021,"Adverse event (headache)",6,1,3,13,1,12,0,0,0,0,0,1.08308675694836,2.769231,0.331462,23.135786,1.17307692307692,0,"6::1","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Kartini 2021",2021,"Adverse event (fatigue)",7,1,2,13,3,12,0,0,0,0,0,0.820412654142367,0.615385,0.123257,3.072438,0.673076923076923,0.686814,"7::1","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Sookprasert 2014",2014,"Adverse event (fatigue)",7,1,89,100,39,45,0,0,0,0,0,0.0682257903947121,1.026923,0.898388,1.173848,0.0046547584749831,99.313186,"7::1","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Sookprasert 2014",2014,"Adverse event (nausea)",8,1,41,101,18,45,0,0,0,0,0,0.218683760569372,1.014851,0.661087,1.557925,0.0478225871367624,0,"8::1","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Grutsch 2021",2021,"One-year survival rate",9,1,23,55,11,29,0,0,0,0,0,0,1.102479,0.629558,1.930657,0,70.019946,"9::1","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Sookprasert 2014",2014,"One-year survival rate",9,1,18,104,6,46,0,0,0,0,0,0,1.326923,0.563598,3.12408,0,29.980054,"9::1","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Grutsch 2021",2021,"Two-year survival rate",10,1,10,55,3,29,0,0,0,0,0,0,1.757576,0.524489,5.889677,0,76.198001,"10::1","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Sookprasert 2014",2014,"Two-year survival rate",10,1,4,104,1,46,0,0,0,0,0,0,1.769231,0.203294,15.397324,0,23.801999,"10::1","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Grutsch 2021",2021,"Three-year survival rate",11,1,9,55,1,29,0,0,0,0,0,0,4.745455,0.631764,35.645198,0,100,"11::1","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Sookprasert 2014",2014,"Three-year survival rate",11,1,0,104,0,46,0,0,0,0,0,0,NA,NA,NA,0,NA,"11::1","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,NA,FALSE
"Seely 2021",2021,"Two-year disease-free survival (DFS) rate",12,1,276,356,268,353,0,0,0,0,0,0,1.021172,0.941613,1.107454,0,0,"12::1","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Seely 2021",2021,"Five-year disease-free survival (DFS) rate",13,1,223,356,223,353,0,0,0,0,0,0,0.991573,0.885583,1.110249,0,0,"13::1","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Grutsch 2021",2021,"Tumour complete response rate (CR) (short term)",14,1,0,30,0,19,0,0,0,0,0,0,NA,NA,NA,0,NA,"14::1","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,NA,FALSE
"Grutsch 2021",2021,"Tumour partial response rate (PR) (short term)",15,1,6,30,2,19,0,0,0,0,0,1.43930125037465,1.9,0.426683,8.460605,2.07158808933002,0,"15::1","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Grutsch 2021",2021,"Tumour stable disease rate (SD) (short term)",16,1,19,30,14,19,0,0,0,0,0,0.683130051063973,0.859524,0.586301,1.260072,0.466666666666667,0,"16::1","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Grutsch 2021",2021,"Tumour progressive disease rate (PD) (short term)",17,1,5,30,3,19,0,0,0,0,0,0.430654918871095,1.055556,0.284544,3.915727,0.18546365914787,0,"17::1","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Kartini 2021",2021,"Positive tumour response rate (CR + PR) (intermediate term)",18,1,5,13,5,12,0,0,0,0,0,0,0.923077,0.353556,2.41,0,0,"18::1","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Kartini 2021",2021,"Negative tumour response rate (SD + PD) (intermediate term)",19,1,8,13,7,12,0,0,0,0,0,0,1.054945,0.554644,2.00653,0,0,"19::1","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Lissoni 1992b",1992,"Improvement in quality of life via Karnofsky's score",1,1,14,31,3,32,0,0,0,0,0,0,4.817204,1.533025,15.137039,0,0,"1::1","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Cerea 2003",2003,"Adverse event (fatigue)",2,1,1,14,3,16,0,0,0,0,0,0,0.380952,0.04453,3.258997,0,0.624826,"2::1","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Lissoni 1997",1997,"Adverse event (fatigue)",2,1,4,39,19,41,0,0,0,0,0,0,0.221323,0.082645,0.592699,0,2.966817,"2::1","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Lissoni 1997a",1997,"Adverse event (fatigue)",2,1,3,34,12,36,0,0,0,0,0,0,0.264706,0.081736,0.857262,0,2.084747,"2::1","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Lissoni 1999",1999,"Adverse event (fatigue)",2,1,33,124,79,126,0,0,0,0,0,0,0.424459,0.307661,0.585598,0,27.797195,"2::1","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Lissoni 2002b",2002,"Adverse event (fatigue)",2,1,25,98,46,102,0,0,0,0,0,0,0.565661,0.379028,0.844192,0,17.958271,"2::1","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Lissoni 2003a",2003,"Adverse event (fatigue)",2,1,4,49,18,51,0,0,0,0,0,0.517596380377514,0.231293,0.084243,0.635024,0.267906012979905,2.82225,"2::1","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Lissoni 2007",2007,"Adverse event (fatigue)",2,1,4,33,17,67,0,0,0,0,0,0,0.477718,0.174643,1.306748,0,2.843068,"2::1","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Lissoni 2007a",2007,"Adverse event (fatigue)",2,1,51,187,96,183,0,0,0,0,0,0,0.519886,0.396209,0.68217,0,39.00697,"2::1","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Lissoni 1994b",1994,"Adverse event (fatigue)",2,2,1,41,3,39,0,0,0,0,0,0,0.317073,0.034427,2.920287,0,0.583977,"2::2","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Lissoni 1998",1998,"Adverse event (fatigue)",2,2,5,40,13,39,0,0,0,0,0,0,0.375,0.147612,0.952665,0,3.31188,"2::2","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Cerea 2003",2003,"Adverse event (nausea)",3,1,3,14,4,16,0,0,0,0,0,0,0.857143,0.230371,3.189178,0,1.609202,"3::1","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Lissoni 1997",1997,"Adverse event (nausea)",3,1,11,39,14,41,0,0,0,0,0,0,0.826007,0.42828,1.593088,0,6.439376,"3::1","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Lissoni 1997a",1997,"Adverse event (nausea)",3,1,7,34,10,36,0,0,0,0,0,0,0.741176,0.318527,1.724635,0,3.895042,"3::1","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Lissoni 1999",1999,"Adverse event (nausea)",3,1,61,124,72,126,0,0,0,0,0,0,0.860887,0.68112,1.088099,0,50.638434,"3::1","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Lissoni 2002b",2002,"Adverse event (nausea)",3,1,46,98,56,102,0,0,0,0,0,0.153200057664104,0.854956,0.649847,1.124803,0.0234702576682847,36.919189,"3::1","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Lissoni 1994b",1994,"Adverse event (nausea)",3,2,1,41,2,39,0,0,0,0,0,0,0.47561,0.044903,5.037582,0,0.498758,"3::2","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Lissoni 1997a",1997,"One-year survival rate",4,1,15,34,7,36,0,0,0,0,0,0,2.268908,1.055827,4.875745,0,16.418666,"4::1","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Lissoni 1999",1999,"One-year survival rate",4,1,63,124,29,126,0,0,0,0,0,0,2.207453,1.535044,3.174402,0,27.298292,"4::1","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Novik 2021",2021,"One-year survival rate",4,1,6,9,11,15,0,0,0,0,0,0,0.909091,0.522583,1.581464,0,21.74757,"4::1","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Lissoni 1995b",1995,"One-year survival rate",4,2,12,19,5,21,0,0,0,0,0,0,2.652632,1.146736,6.136072,0,14.873716,"4::2","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Lissoni 1996a",1996,"One-year survival rate",4,3,6,14,1,16,0,0,0,0,0,0,6.857143,0.935665,50.253451,0,4.13143,"4::3","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Lissoni 1994b",1994,"One-year survival rate",4,4,19,41,6,39,0,0,0,0,0,0,3.012195,1.344873,6.746601,0,15.530326,"4::4","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Lissoni 2008b",2008,"Two-year survival rate",5,1,6,285,0,286,0,0,0,0,0,0,13.045455,0.738351,230.491804,0,6.730014,"5::1","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Lissoni 2007a",2007,"Two-year survival rate",5,2,47,187,24,183,0,0,0,0,0,0,1.916444,1.225032,2.99809,0,71.812784,"5::2","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Lissoni 1998",1998,"Two-year survival rate",5,3,9,40,2,39,0,0,0,0,0,0,4.3875,1.011507,19.031163,0,21.457202,"5::3","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Lissoni 2008b",2008,"Three-year survival rate",6,1,0,285,0,286,0,0,0,0,0,0,NA,NA,NA,0,NA,"6::1","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,NA,FALSE
"Lissoni 1998",1998,"Three-year survival rate",6,2,4,40,0,39,0,0,0,0,0,0,8.780488,0.48843,157.846427,0,49.854515,"6::2","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Lissoni 2000",2000,"Three-year survival rate",6,2,3,14,0,16,0,0,0,0,0,0,7.933333,0.445026,141.425025,0,50.145485,"6::2","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Lissoni 2003a",2003,"Five-year survival rate",7,1,3,49,0,51,0,0,0,0,0,0,7.28,0.385769,137.383811,0,0,"7::1","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Lissoni 1996a",1996,"Progression-free survival (PFS)",8,1,0,14,0,16,8,11.224972,3,4,0,0.839855429736061,5,-1.19795,11.19795,0.705357142857143,16.666667,"8::1","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE
"Lissoni 1994b",1994,"Progression-free survival (PFS)",8,2,0,41,0,39,9,6.403124,4,6.244998,0,0.223676707646247,5,2.228192,7.771808,0.0500312695434646,83.333333,"8::2","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE
"Lissoni 1996",1996,"One-year disease-free survival (DFS) rate",9,1,10,14,5,16,0,0,0,0,0,0,2.285714,1.028351,5.080453,0,0,"9::1","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Semiglazova 2018",2018,"Tumour complete response rate (CR) defined by RECIST (intermediate term)",10,1,0,16,0,19,0,0,0,0,0,0,NA,NA,NA,0,NA,"10::1","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,NA,FALSE
"Semiglazova 2018",2018,"Tumour partial response rate (PR) defined by RECIST (intermediate term)",11,1,13,16,6,19,0,0,0,0,0,0,2.572917,1.274518,5.194041,0,0,"11::1","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Semiglazova 2018",2018,"Tumour stable disease rate (SD) defined by RECIST (intermediate term)",12,1,3,16,13,19,0,0,0,0,0,0,0.274038,0.094492,0.794749,0,0,"12::1","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Semiglazova 2018",2018,"Tumour progressive disease rate (PD) defined by RECIST (intermediate term)",13,1,0,16,0,19,0,0,0,0,0,0,NA,NA,NA,0,NA,"13::1","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,NA,FALSE
"Novik 2021",2021,"Tumour complete response rate (CR) defined by RECIST (long term)",14,1,1,20,0,19,0,0,0,0,0,0,2.857143,0.123482,66.108754,0,0,"14::1","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Novik 2021",2021,"Tumour partial response rate (PR) defined by RECIST (long term)",15,1,0,20,2,19,0,0,0,0,0,0,0.190476,0.009733,3.727518,0,0,"15::1","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Novik 2021",2021,"Tumour stable disease rate (SD) defined by RECIST (long term)",16,1,5,20,5,19,0,0,0,0,0,0,0.95,0.32625,2.766283,0,0,"16::1","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Novik 2021",2021,"Tumour progressive disease rate (PD) defined by RECIST (long term)",17,1,13,20,11,19,0,0,0,0,0,0,1.122727,0.680652,1.851926,0,0,"17::1","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Lissoni 1992b",1992,"(Additional table) CR until progression of the disease",18,NA,0,31,0,32,0,0,0,0,0,0,NA,NA,NA,0,NA,"18::overall","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,NA,FALSE
"Lissoni 1994b",1994,"(Additional table) CR until progression of the disease",18,NA,3,41,0,39,0,0,0,0,0,1.50350056246102,6.666667,0.35549,125.023045,2.26051394132062,6.405221,"18::overall","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Lissoni 1995b",1995,"(Additional table) CR until progression of the disease",18,NA,0,19,0,21,0,0,0,0,0,1.6177998710484,NA,NA,NA,2.61727642276423,NA,"18::overall","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,NA,FALSE
"Lissoni 1997",1997,"(Additional table) CR until progression of the disease",18,NA,1,39,0,41,0,0,0,0,0,1.61687529336239,3.15,0.132155,75.082213,2.61428571428571,5.473128,"18::overall","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Lissoni 1997a",1997,"(Additional table) CR until progression of the disease",18,NA,1,34,0,36,0,0,0,0,0,1.61717327325714,3.171429,0.133603,75.28258,2.6152493957372,5.487359,"18::overall","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Lissoni 1998",1998,"(Additional table) CR until progression of the disease",18,NA,1,40,0,39,0,0,0,0,0,1.45067429492072,2.926829,0.122835,69.738265,2.10445590994371,5.474343,"18::overall","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Lissoni 1999",1999,"(Additional table) CR until progression of the disease",18,NA,6,124,0,126,0,0,0,0,0,1.44197970562399,13.208,0.752015,231.978349,2.07930547143146,6.701616,"18::overall","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Lissoni 2000",2000,"(Additional table) CR until progression of the disease",18,NA,0,14,0,16,0,0,0,0,0,0,NA,NA,NA,0,NA,"18::overall","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,NA,FALSE
"Lissoni 2002a",2002,"(Additional table) CR until progression of the disease",18,NA,0,722,0,718,0,0,0,0,0,0,NA,NA,NA,0,NA,"18::overall","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,NA,FALSE
"Lissoni 2002b",2002,"(Additional table) CR until progression of the disease",18,NA,3,98,0,102,0,0,0,0,0,1.50529217687105,7.282828,0.38106,139.189698,2.2659045377492,6.323244,"18::overall","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Lissoni 2003a",2003,"(Additional table) CR until progression of the disease",18,NA,2,49,0,51,0,0,0,0,0,1.53647949246621,5.2,0.255947,105.646973,2.36076923076923,6.069152,"18::overall","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Lissoni 2007",2007,"(Additional table) CR until progression of the disease",18,NA,1,33,0,35,0,0,0,0,0,1.61538760803189,3.176471,0.133944,75.329531,2.60947712418301,5.490705,"18::overall","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Lissoni 2007a",2007,"(Additional table) CR until progression of the disease",18,NA,12,187,5,183,0,0,0,0,0,0.522035687358756,2.348663,0.844235,6.533988,0.272521258876129,52.575232,"18::overall","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Lissoni 2008b",2008,"(Additional table) CR until progression of the disease",18,NA,0,285,0,286,0,0,0,0,0,0,NA,NA,NA,0,NA,"18::overall","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,NA,FALSE
"Lissoni 1992b",1992,"(Additional table) PR until progression of the disease",19,NA,0,31,0,32,0,0,0,0,0,0,NA,NA,NA,0,NA,"19::overall","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,NA,FALSE
"Lissoni 1994b",1994,"(Additional table) PR until progression of the disease",19,NA,8,41,1,39,0,0,0,0,0,1.43834541575173,7.609756,0.99733,58.063398,2.06883753501401,1.392763,"19::overall","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Lissoni 1995b",1995,"(Additional table) PR until progression of the disease",19,NA,7,19,2,21,0,0,0,0,0,1.6177998710484,3.868421,0.91311,16.388695,2.61727642276423,2.716502,"19::overall","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Lissoni 1996c",1996,"(Additional table) PR until progression of the disease",19,NA,9,58,3,58,0,0,0,0,0,0.632001018477282,3,0.855287,10.522785,0.399425287356322,3.559425,"19::overall","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Lissoni 1997a",1997,"(Additional table) PR until progression of the disease",19,NA,10,34,6,36,0,0,0,0,0,0.46001508270899,1.764706,0.719596,4.327688,0.211613876319759,6.703191,"19::overall","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Lissoni 1998",1998,"(Additional table) PR until progression of the disease",19,NA,6,40,1,39,0,0,0,0,0,1.45067429492072,5.85,0.737783,46.3856,2.10445590994371,1.342317,"19::overall","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Lissoni 1999",1999,"(Additional table) PR until progression of the disease",19,NA,36,124,19,126,0,0,0,0,0,1.41828179306016,1.925297,1.170774,3.166084,2.01152324452594,18.573142,"19::overall","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Lissoni 2000",2000,"(Additional table) PR until progression of the disease",19,NA,4,14,1,16,0,0,0,0,0,1.4480096775035,4.571429,0.576509,36.249139,2.09673202614379,1.342263,"19::overall","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Lissoni 2002a",2002,"(Additional table) PR until progression of the disease",19,NA,17,722,0,718,0,0,0,0,0,0,34.806362,2.097131,577.685882,0,0.73439,"19::overall","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Lissoni 2002b",2002,"(Additional table) PR until progression of the disease",19,NA,29,98,20,102,0,0,0,0,0,1.41918587828362,1.509184,0.9175,2.482437,2.01408855711966,18.558095,"19::overall","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Lissoni 2003a",2003,"(Additional table) PR until progression of the disease",19,NA,15,49,9,51,0,0,0,0,0,1.42312520875764,1.734694,0.838086,3.590518,2.02528535980149,9.799097,"19::overall","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Lissoni 2007",2007,"(Additional table) PR until progression of the disease",19,NA,12,33,6,35,0,0,0,0,0,0.441935205425559,2.121212,0.900444,4.997026,0.195306725794531,7.29279,"19::overall","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Lissoni 2007a",2007,"(Additional table) PR until progression of the disease",19,NA,56,187,32,183,0,0,0,0,0,0.455022052652328,1.712567,1.167011,2.513161,0.207045068399938,27.263454,"19::overall","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Lissoni 2008b",2008,"(Additional table) PR until progression of the disease",19,NA,10,285,0,286,0,0,0,0,0,0,21.073427,1.240739,357.923158,0,0.722571,"19::overall","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Lissoni 1992b",1992,"(Additional table) SD until progression of the disease",20,NA,10,31,3,32,0,0,0,0,0,1.42607330279164,3.44086,1.044777,11.332101,2.03368506493507,4.342048,"20::overall","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Lissoni 1994b",1994,"(Additional table) SD until progression of the disease",20,NA,12,41,11,39,0,0,0,0,0,0,1.037694,0.520086,2.070444,1.03330206378987,7.323855,"20::overall","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Lissoni 1995b",1995,"(Additional table) SD until progression of the disease",20,NA,8,19,9,21,0,0,0,0,0,0.724395867902064,0.982456,0.477053,2.023297,0.524749373433584,7.092833,"20::overall","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Lissoni 1997a",1997,"(Additional table) SD until progression of the disease",20,NA,15,34,16,36,0,0,0,0,0,0.419694878274292,0.992647,0.586719,1.679422,0.176143790849673,8.576389,"20::overall","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Lissoni 1999",1999,"(Additional table) SD until progression of the disease",20,NA,56,124,53,126,0,0,0,0,0,0.233426000563286,1.073646,0.809699,1.423635,0.054487697738971,10.3058,"20::overall","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Lissoni 2000",2000,"(Additional table) SD until progression of the disease",20,NA,5,14,6,16,0,0,0,0,0,1.03250735037162,0.952381,0.36997,2.451632,1.06607142857143,5.618877,"20::overall","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Lissoni 2002a",2002,"(Additional table) SD until progression of the disease",20,NA,171,722,54,718,0,0,0,0,0,1.41529394732737,3.149123,2.361141,4.200078,2.00305695734149,10.270861,"20::overall","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Lissoni 2002b",2002,"(Additional table) SD until progression of the disease",20,NA,43,98,36,102,0,0,0,0,0,0.230754871567661,1.243197,0.880255,1.755785,0.0532478107522078,9.904376,"20::overall","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Lissoni 2003a",2003,"(Additional table) SD until progression of the disease",20,NA,26,49,22,51,0,0,0,0,0,0.330993418620505,1.230056,0.815789,1.854691,0.109556643170088,9.444614,"20::overall","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Lissoni 2007",2007,"(Additional table) SD until progression of the disease",20,NA,16,33,12,35,0,0,0,0,0,0.412664764418054,1.414141,0.793385,2.520588,0.170292207792208,8.175369,"20::overall","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Lissoni 2007a",2007,"(Additional table) SD until progression of the disease",20,NA,69,187,55,183,0,0,0,0,0,0.186897509790751,1.22771,0.918835,1.640417,0.0349306791659837,10.259845,"20::overall","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Lissoni 2008b",2008,"(Additional table) SD until progression of the disease",20,NA,79,285,16,286,0,0,0,0,0,1.41619129791784,4.954825,2.970384,8.265021,2.00559779229821,8.685134,"20::overall","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Lissoni 1992b",1992,"(Additional table) PD until progression of the disease",21,NA,20,31,29,32,0,0,0,0,0,0.565530961855498,0.711902,0.535974,0.945577,0.319825268817204,11.192396,"21::overall","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Lissoni 1994b",1994,"(Additional table) PD until progression of the disease",21,NA,18,41,27,39,0,0,0,0,0,0.310537239185869,0.634146,0.423237,0.950158,0.0964333769211818,7.18809,"21::overall","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Lissoni 1995b",1995,"(Additional table) PD until progression of the disease",21,NA,4,19,10,21,0,0,0,0,0,0.510745028898662,0.442105,0.166012,1.17737,0.260860484544695,1.621177,"21::overall","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Lissoni 1997a",1997,"(Additional table) PD until progression of the disease",21,NA,7,34,14,36,0,0,0,0,0,0.384925447812278,0.529412,0.243454,1.151252,0.148167600373483,2.480135,"21::overall","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Lissoni 1999",1999,"(Additional table) PD until progression of the disease",21,NA,26,124,54,126,0,0,0,0,0,0.203293971687062,0.489247,0.329016,0.727511,0.0413284389243001,7.38167,"21::overall","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Lissoni 2000",2000,"(Additional table) PD until progression of the disease",21,NA,5,14,9,16,0,0,0,0,0,0.482429368133922,0.634921,0.278242,1.448826,0.232738095238095,2.224608,"21::overall","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Lissoni 2002a",2002,"(Additional table) PD until progression of the disease",21,NA,532,722,664,718,0,0,0,0,0,0.13274192463282,0.796766,0.759178,0.836215,0.0176204185552251,23.592483,"21::overall","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Lissoni 2002b",2002,"(Additional table) PD until progression of the disease",21,NA,23,98,46,102,0,0,0,0,0,0.226380289438066,0.520408,0.34305,0.789461,0.0512480354460624,6.885881,"21::overall","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Lissoni 2003a",2003,"(Additional table) PD until progression of the disease",21,NA,6,49,20,51,0,0,0,0,0,0.414855644433881,0.312245,0.137005,0.711629,0.172105205718651,2.230694,"21::overall","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Lissoni 2007",2007,"(Additional table) PD until progression of the disease",21,NA,4,33,17,35,0,0,0,0,0,0.523888227066494,0.249554,0.093672,0.664848,0.274458874458874,1.619967,"21::overall","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Lissoni 2007a",2007,"(Additional table) PD until progression of the disease",21,NA,50,187,91,183,0,0,0,0,0,0.16543803590654,0.537698,0.407032,0.710309,0.0273697437246135,11.427661,"21::overall","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Lissoni 2008b",2008,"(Additional table) PD until progression of the disease",21,NA,196,285,270,286,0,0,0,0,0,0.246164102561682,0.728473,0.67034,0.791647,0.0605967653899984,22.155239,"21::overall","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Lissoni 1997a",1997,"One-year survival rate without Novik 2021",22,1,15,34,7,36,0,0,0,0,0,0,2.268908,1.055827,4.875745,0,13.673015,"22::1","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Lissoni 1999",1999,"One-year survival rate without Novik 2021",22,1,63,124,29,126,0,0,0,0,0,0,2.207453,1.535044,3.174402,0,60.628261,"22::1","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Lissoni 1995b",1995,"One-year survival rate without Novik 2021",22,2,12,19,5,21,0,0,0,0,0,0,2.652632,1.146736,6.136072,0,11.376655,"22::2","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Lissoni 1996a",1996,"One-year survival rate without Novik 2021",22,3,6,14,1,16,0,0,0,0,0,0,6.857143,0.935665,50.253451,0,2.016841,"22::3","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Lissoni 1994b",1994,"One-year survival rate without Novik 2021",22,4,19,41,6,39,0,0,0,0,0,0,3.012195,1.344873,6.746601,0,12.305228,"22::4","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Ben-David 2016",2016,"Adverse events (related to the study treatment)",1,NA,4,26,0,21,0,0,0,0,0,0,7.333333,0.417042,128.950659,0,5.485017,"1::overall","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Lozano 2021",2021,"Adverse events (related to the study treatment)",1,NA,11,40,8,39,0,0,0,0,0,0.316227766016838,1.340625,0.60432,2.974047,0.1,71.014677,"1::overall","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Zetner 2023",2023,"Adverse events (related to the study treatment)",1,NA,4,26,3,22,0,0,0,0,0,0,1.128205,0.282389,4.507416,0,23.500306,"1::overall","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Lozano 2021",2021,"Incidence of anaemia at least grade 3",2,NA,2,40,2,39,0,0,0,0,0,0,0.975,0.144423,6.582234,0,0,"2::overall","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Lozano 2021",2021,"Incidence of neutropenia at least grade 3",3,NA,3,40,2,39,0,0,0,0,0,0,1.4625,0.258249,8.282339,0,0,"3::overall","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Lozano 2021",2021,"Incidence of nausea at least grade 3",4,NA,2,40,2,39,0,0,0,0,0,0,0.975,0.144423,6.582234,0,0,"4::overall","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Lozano 2021",2021,"Incidence of vomiting at least grade 3",5,NA,2,40,3,39,0,0,0,0,0,0,0.65,0.114777,3.68104,0,0,"5::overall","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Lozano 2021",2021,"Incidence of anorexia at least grade 3",6,NA,3,40,0,39,0,0,0,0,0,0,6.829268,0.364299,128.023661,0,0,"6::overall","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Lozano 2021",2021,"Incidence of renal failure at least grade 3",7,NA,0,40,1,39,0,0,0,0,0,0,0.325203,0.013648,7.748696,0,0,"7::overall","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Lozano 2021",2021,"Incidence of oral mucositis at least grade 3",8,NA,20,40,26,39,0,0,0,0,0,0,0.75,0.512299,1.097991,0,0,"8::overall","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Lozano 2021",2021,"Incidence of cheilitis at least grade 3",9,NA,1,40,2,39,0,0,0,0,0,0,0.4875,0.046049,5.160959,0,0,"9::overall","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Lozano 2021",2021,"Incidence of radiation skin injury at least grade 3",10,NA,1,40,2,39,0,0,0,0,0,0,0.4875,0.046049,5.160959,0,0,"10::overall","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Ben-David 2016",2016,"Incidence of dermatitis at least grade 3",11,NA,0,26,0,21,0,0,0,0,0,0,NA,NA,NA,0,NA,"11::overall","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,NA,FALSE
"Lozano 2021",2021,"Incidence of dermatitis at least grade 3",11,NA,2,40,6,39,0,0,0,0,0,0,0.325,0.069791,1.513451,0,100,"11::overall","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Ben-David 2016",2016,"Incidence of allergies at least grade 3",12,NA,1,26,0,21,0,0,0,0,0,0,2.444444,0.104675,57.084489,0,0,"12::overall","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Lozano 2021",2021,"Incidence of pneumonia at least grade 3",13,NA,2,40,0,39,0,0,0,0,0,0,4.878049,0.241663,98.465178,0,0,"13::overall","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
"Lozano 2021",2021,"Incidence of asthenia at least grade 3",14,NA,4,40,3,39,0,0,0,0,0,0,1.3,0.310948,5.434998,0,0,"14::overall","CD010145_pub2_data",FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE
